Skip to main content

Table 1 Demographic characteristics of the participants in this study cohort

From: Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies

 

Cases (trios)

Fetal sex (male:female)

Gestational week (weeks)

Maternal age (years)

Paternal age (years)

Total

959

0.58:0.42

23.6 (22.25–26.4)

28 (26–31)

32 (29–34)

 Cardiac

265

0.60:0.40

24 (22.6–24.6)

28 (26–31)

32 (30–35)

 Chest and respiratory tract

43

0.49:0.51

24.1 (23.15–26.15)

28 (26–30)

31 (30–33.5)

 CNS

116

0.53:0.47

26.45 (23.075–31.2)

28.5 (26–31)

32 (29–35)

 Facial

127

0.69:0.31

23.2 (22.4–24.35)

28 (25.5–30)

31 (29–34)

 Gastrointestinal tract and AW

42

0.57:0.43

24 (14.5–28.125)

29 (27–30)

32 (30–34)

 Genitourinary

94

0.62:0.38

24.3 (23–29.45)

29 (27–31)

32 (29–34)

 Hydrops

31

0.58:0.42

24.2 (21.5–30.5)

28 (25–31)

32 (28–35)

 Increased NT

20

0.60:0.40

13 (12.5–13.3)

28 (27–30)

31 (30–34)

 Skeletal

94

0.53:0.47

23.8 (22.15–25.975)

29 (26–32)

32 (30–35)

 Multisystem

127

0.54:0.46

22.6 (14.45–24.25)

28 (25–30)

31 (29–33)

  1. Fetuses were counted once. Data were shown as median (first quartile to third quartile)
  2. CNS central nervous system; AW abdominal wall; NT nuchal translucency